Markus von Deimling

6PUBLICATIONS
39CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Mar 12, 2024
The optimal number of induction chemotherapy cycles in clinically lymph node-positive bladder cancer.

Markus von Deimling, Laura S Mertens, Marc Furrer

|Jul 06, 2023
Low-dose or -number of BCG in non-muscle invasive bladder cancer: updated systematic review and meta-analysis.

Tatsushi Kawada, Takafumi Yanagisawa, Kensuke Bekku

|Jun 09, 2023
Clinical value of cholinesterase in patients treated with radical nephroureterectomy for upper urinary tract carcinoma.

Markus von Deimling, David D'Andrea, Benjamin Pradere

|Dec 08, 2022
Oncological impact of cystoscopic findings in non-muscle-invasive bladder cancer: a meta-analysis.

Takafumi Yanagisawa, Fahad Quhal, Tatsushi Kawada

|Sep 11, 2022
Oncological validation and discriminative ability of pentafecta criteria after open radical cystectomy.

Markus von Deimling, Michael Rink, Jakob Klemm

Pageof 1